StockData
Stevanato Group S.p.A. logo

Stevanato Group S.p.A. (STVN) stock

STVNNYSESurgical & Medical Instruments & Apparatus
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026Score 8/30
$15.25−0.28 (-1.80%)

Close on Nov 17, 2026Market cap $4.62BP/E 27.1Yield –

Earnings

Stevanato Group S.p.A.'s quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2025
€346.00M
+4.5% on a year earlier
adjusted diluted EPS*, Q4 FY2025
0.18 EUR
0.19 EUR a year earlier
Latest guidance
Issued
Mar 4, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of Stevanato Group S.p.A.'s earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2025ended Dec 31, 2025Mar 4, 2026during market hours€346.00M+4.5%0.17 EUR0.18 EURRelease
Q4 FY2024ended Dec 31, 2024Mar 6, 2025during market hours€331.00M+3.2%0.18 EUR0.19 EURRelease
Q4 FY2023ended Dec 31, 2023Mar 7, 2024during market hours€320.60M–0.17 EUR0.18 EURRelease
Q4 FY2022ended Dec 31, 2022Mar 2, 2023before the open––––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Stevanato Group S.p.A.'s latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Implied Revenue GrowthFY2025+5% – +8%–NewMar 6, 2025
RevenueGAAPFY20251.16 – 1.19–NewMar 6, 2025
Adjusted EBITDA*non-GAAPFY2025293 – 306.3–NewMar 6, 2025
Adjusted DEPS*non-GAAPFY20250.51 – 0.55–NewMar 6, 2025
Free cash flownon-GAAPFY2025-60 – -40–NewMar 6, 2025
capexnon-GAAPFY2025250 – 280–NewMar 6, 2025
Total capital expendituresGAAPFY2025310 – 340–NewMar 6, 2025
RevenueGAAPFY20261.26 – 1.29–NewMar 4, 2026
Revenue at Constant Currencynon-GAAPFY20261.28 – 1.31–NewMar 4, 2026
Adjusted EBITDA*non-GAAPFY2026331.8 – 346.9–NewMar 4, 2026
Adjusted DEPS*non-GAAPFY20260.59 – 0.63–NewMar 4, 2026
Total capital expendituresnon-GAAPFY2026270 – 290–NewMar 4, 2026

Guidance history

Every forecast Stevanato Group S.p.A. put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 4, 2026Total capital expendituresFY2026270 – 290New
Mar 4, 2026Adjusted EBITDA*FY2026331.8 – 346.9New
Mar 4, 2026Adjusted DEPS*FY20260.59 – 0.63New
Mar 4, 2026RevenueFY20261.26 – 1.29New
Mar 4, 2026Revenue at Constant CurrencyFY20261.28 – 1.31New
Mar 6, 2025Total capital expendituresFY2025310 – 340New
Mar 6, 2025capexFY2025250 – 280New
Mar 6, 2025Adjusted EBITDA*FY2025293 – 306.3New
Mar 6, 2025Adjusted DEPS*FY20250.51 – 0.55New
Mar 6, 2025Free cash flowFY2025-60 – -40New
Mar 6, 2025RevenueFY20251.16 – 1.19New
Mar 6, 2025Implied Revenue GrowthFY2025+5% – +8%New
Mar 7, 2024Capital expendituresFY202425% – 28%New
Mar 7, 2024EBITDAFY2024302.8 – 318.2New
Mar 7, 2024Adjusted EBITDAFY2024314.1 – 329.5New
Mar 7, 2024Adjusted DEPSFY20240.62 – 0.66New
Mar 7, 2024Diluted EPSFY20240.58 – 0.63New
Mar 7, 2024Operating ProfitFY2024217.7 – 233New
Mar 7, 2024Operating ProfitFY2024228.9 – 244.3New
Mar 7, 2024RevenueFY20241.18 – 1.21New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Stevanato Group S.p.A. filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?